CME Group Inc. (NASDAQ:CME) Shares Sold by Troy Asset Management Ltd

Troy Asset Management Ltd trimmed its position in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 8.7% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 587,896 shares of the financial services provider’s stock after selling 56,290 shares during the period. CME Group makes up 3.7% of Troy Asset Management Ltd’s portfolio, making the stock its 8th biggest holding. Troy Asset Management Ltd’s holdings in CME Group were worth $115,580,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Salomon & Ludwin LLC bought a new position in CME Group in the 1st quarter worth approximately $28,000. Y.D. More Investments Ltd bought a new stake in CME Group in the 2nd quarter valued at $36,000. McClarren Financial Advisors Inc. grew its position in CME Group by 66.1% in the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock worth $39,000 after purchasing an additional 78 shares during the last quarter. Asset Dedication LLC increased its holdings in shares of CME Group by 515.2% during the 2nd quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock worth $40,000 after purchasing an additional 170 shares during the period. Finally, Rise Advisors LLC bought a new position in shares of CME Group during the 1st quarter worth about $41,000. 87.75% of the stock is owned by institutional investors and hedge funds.

Insider Activity at CME Group

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the transaction, the director now owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In related news, CFO Lynne Fitzpatrick sold 754 shares of the business’s stock in a transaction that occurred on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the sale, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at $2,877,504.39. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares in the company, valued at $11,932,706.13. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by company insiders.

CME Group Trading Up 1.1 %

Shares of CME opened at $220.65 on Tuesday. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.02. The company has a market cap of $79.45 billion, a price-to-earnings ratio of 25.10, a PEG ratio of 8.74 and a beta of 0.55. The stock has a fifty day moving average price of $210.11 and a two-hundred day moving average price of $207.42. CME Group Inc. has a 52-week low of $190.70 and a 52-week high of $223.80.

CME Group (NASDAQ:CMEGet Free Report) last released its quarterly earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.53 by $0.03. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The business had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.53 billion. During the same period in the previous year, the business posted $2.30 earnings per share. The firm’s revenue for the quarter was up 12.7% compared to the same quarter last year. Analysts predict that CME Group Inc. will post 9.94 EPS for the current fiscal year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th were paid a dividend of $1.15 per share. The ex-dividend date was Monday, September 9th. This represents a $4.60 annualized dividend and a dividend yield of 2.08%. CME Group’s dividend payout ratio (DPR) is currently 52.33%.

Analyst Ratings Changes

CME has been the topic of a number of recent research reports. Deutsche Bank Aktiengesellschaft lifted their target price on CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a research report on Thursday, August 15th. JPMorgan Chase & Co. lifted their price objective on CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a report on Thursday, July 25th. TD Cowen began coverage on CME Group in a research report on Thursday, September 26th. They issued a “hold” rating and a $221.00 target price for the company. Keefe, Bruyette & Woods boosted their price target on shares of CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a report on Thursday, July 25th. Finally, Barclays raised their price objective on shares of CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a report on Thursday, July 25th. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $212.54.

Check Out Our Latest Stock Report on CME Group

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Further Reading

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.